Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CAPIVASERTIB vs CARBAMAZEPINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CAPIVASERTIB vs CARBAMAZEPINE: Safety Overview

Metric CAPIVASERTIB CARBAMAZEPINE
Total FAERS Reports 1,691 24,577
Deaths Reported 285 2,156
Death Rate 16.9% 8.8%
Hospitalizations 464 9,608
Average Patient Age 66.2 yrs 50.1 yrs
% Female Patients 94.6% 61.8%
FDA Approval Date Nov 16, 2023 Approved Prior to Jan 1, 1982
Manufacturer AstraZeneca Pharmaceuticals LP REMEDYREPACK INC.
Route ORAL ORAL
Marketing Status Prescription Prescription